Peg Taylor

Peg Taylor currently serves as the Vice President of Clinical Development Operations at Synthekine, a position held since January 2023. Prior to this role, Peg Taylor was the Executive Director of Clinical Operations at CRISPR Therapeutics from July 2021 to December 2022 and the Vice President of Clinical Operations at Adicet Bio, Inc. from August 2019 to July 2021. Additional experience includes senior leadership roles at Nektar Therapeutics, Genentech, Bayhill Therapeutics, IQVIA, Telik, Inc., MedImmune, and Human Genome Sciences. Peg Taylor holds a Bachelor of Science degree in Nutrition Science from the University of California, Davis, earned between 1981 and 1986.